Document is current
Any future updates will be listed below
-
Authors
Huggler, Kimberly S. https://orcid.org/0000-0003-0289-3167
Flickinger, Kyle M. https://orcid.org/0009-0003-3538-5887
Forsberg, Matthew H.
Mellado Fritz, Carlos A. https://orcid.org/0009-0008-9040-9243
Chang, Gavin R. https://orcid.org/0009-0000-1439-8767
McGuire, Meghan F. https://orcid.org/0009-0003-8032-6771
Capitini, Christian M.
Cantor, Jason R. https://orcid.org/0000-0001-5263-2059
-
Funding
Funding for this research was provided by:
American Cancer Society
-St. Baldrick’s Foundation Empowering Pediatric Immunotherapy for Childhood Cancers Team Grant -Midwest Athletes Against Childhood Cancer (MACC) Fund
- License Information
-
More Information
Article History
Received: 21 January 2025
Accepted: 14 November 2025
First Online: 16 January 2026
Competing interests
: J.R.C. is an inventor on an issued patent for HPLM assigned to the Whitehead Institute (Patent number US11453858). C.M.C. reports honorarium from Bayer and Novartis, and equity interest from Elephas, for advisory board memberships. These entities had no input in the study design, analysis, manuscript preparation or decision to submit for publication. The other authors declare no competing interests.
